Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
AstraZeneca PLC (AZN) had Receiveable Turnover of 3.60 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$58.74B |
|
$10.22B |
|
$10.63B |
|
$48.11B |
|
$45.00B |
|
$13.74B |
|
$-1.34B |
|
$12.40B |
|
$12.40B |
|
$10.23B |
|
$10.23B |
|
$10.23B |
|
$10.23B |
|
$13.74B |
|
$19.48B |
|
3.10B |
|
3.12B |
|
$3.30 |
|
$3.27 |
|
| Balance Sheet Financials | |
$28.72B |
|
$12.96B |
|
$85.35B |
|
$114.07B |
|
$30.62B |
|
$24.71B |
|
$34.74B |
|
$65.36B |
|
$48.72B |
|
$-10.37B |
|
$48.72B |
|
3.10B |
|
| Cash Flow Statement Financials | |
$14.57B |
|
$-6.81B |
|
$-7.54B |
|
$5.43B |
|
$5.70B |
|
$269.00M |
|
-- |
|
$-4.97B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.94 |
|
-- |
|
-- |
|
0.34 |
|
0.57 |
|
81.90% |
|
23.40% |
|
23.40% |
|
33.16% |
|
21.11% |
|
17.41% |
|
$11.78B |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
1.62 |
|
|
Receiveable Turnover |
3.60 |
101.50 |
|
21.00% |
|
-98.69% |
|
8.97% |
|
13.94% |
|
$15.71 |
|
$3.77 |
|
$4.67 |
|